BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23333936)

  • 41. Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.
    Flote VG; Furberg AS; McTiernan A; Frydenberg H; Ursin G; Iversen A; Lofteroed T; Ellison PT; Wist EA; Egeland T; Wilsgaard T; Makar KW; Chang-Claude J; Thune I
    Breast Cancer Res; 2014 Dec; 16(6):499. PubMed ID: 25522654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
    Chen XH; Li XQ; Chen Y; Feng YM
    Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study.
    Heusinger K; Jud SM; Häberle L; Hack CC; Adamietz BR; Meier-Meitinger M; Lux MP; Wittenberg T; Wagner F; Loehberg CR; Uder M; Hartmann A; Schulz-Wendtland R; Beckmann MW; Fasching PA
    Int J Cancer; 2012 Dec; 131(11):2643-9. PubMed ID: 22392346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for breast cancer associated with mammographic features in Singaporean chinese women.
    Heng D; Gao F; Jong R; Fishell E; Yaffe M; Martin L; Li T; Stone J; Sun L; Hopper J; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1751-8. PubMed ID: 15533903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer risk factors and mammographic breast density in women over age 70.
    Modugno F; Ngo DL; Allen GO; Kuller LH; Ness RB; Vogel VG; Costantino JP; Cauley JA
    Breast Cancer Res Treat; 2006 May; 97(2):157-66. PubMed ID: 16362132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic variation in TGFB1 gene and risk of idiopathic recurrent pregnancy loss.
    Magdoud K; Granados Herbepin V; Messaoudi S; Hizem S; Bouafia N; Almawi WY; Mahjoub T; Touraine R
    Mol Hum Reprod; 2013 Jul; 19(7):438-43. PubMed ID: 23416372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study.
    Cox DG; Penney K; Guo Q; Hankinson SE; Hunter DJ
    BMC Cancer; 2007 Sep; 7():175. PubMed ID: 17848193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
    Krela-Kaźmierczak I; Michalak M; Wawrzyniak A; Szymczak A; Eder P; Łykowska-Szuber L; Kaczmarek-Ryś M; Drwęska-Matelska N; Skrzypczak-Zielińska M; Linke K; Słomski R
    Mol Biol Rep; 2017 Dec; 44(6):455-461. PubMed ID: 28993955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China.
    Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G; Shan B
    Int J Immunogenet; 2011 Jun; 38(3):215-24. PubMed ID: 21205231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic association and gene expression profiles of TGFB1 and the contribution of TGFB1 to otosclerosis susceptibility.
    Priyadarshi S; Ray CS; Panda KC; Desai A; Nayak SR; Biswal NC; Ramchander PV
    J Bone Miner Res; 2013 Dec; 28(12):2490-7. PubMed ID: 23703862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.
    Castillejo A; Rothman N; Murta-Nascimento C; Malats N; García-Closas M; Gómez-Martínez A; Lloreta J; Tardón A; Serra C; García-Closas R; Chanock S; Silverman DT; Dosemeci M; Kogevinas M; Carrato A; Soto JL; Real FX
    Int J Cancer; 2009 Feb; 124(3):608-13. PubMed ID: 19004027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pituitary growth hormone and growth hormone-releasing hormone receptor genes and associations with mammographic measures and serum growth hormone.
    Mulhall C; Hegele RA; Cao H; Tritchler D; Yaffe M; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2648-54. PubMed ID: 16284391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
    Vitiello GAF; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
    Breast Cancer Res Treat; 2019 Nov; 178(1):207-219. PubMed ID: 31364002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Genetic Polymorphisms of TGF-β1, HMOX1, and APOL1 With CKD in Nigerian Patients With and Without HIV.
    Ekrikpo UE; Mnika K; Effa EE; Ajayi SO; Okwuonu C; Waziri B; Bello A; Dandara C; Kengne AP; Wonkam A; Okpechi I
    Am J Kidney Dis; 2020 Jul; 76(1):100-108. PubMed ID: 32354559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.
    Langdahl BL; Uitterlinden AG; Ralston SH; Trikalinos TA; Balcells S; Brandi ML; Scollen S; Lips P; Lorenc R; Obermayer-Pietsch B; Reid DM; Armas JB; Arp PP; Bassiti A; Bustamante M; Husted LB; Carey AH; Pérez Cano R; Dobnig H; Dunning AM; Fahrleitner-Pammer A; Falchetti A; Karczmarewicz E; Kruk M; van Leeuwen JP; Masi L; van Meurs JB; Mangion J; McGuigan FE; Mellibovsky L; Mosekilde L; Nogués X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Ioannidis JP; ; ; ; ; ; ; ;
    Bone; 2008 May; 42(5):969-81. PubMed ID: 18284942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormone therapy, mammographic density, and breast cancer risk.
    Martin LJ; Minkin S; Boyd NF
    Maturitas; 2009 Sep; 64(1):20-6. PubMed ID: 19709825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.
    Bremer LA; Blackman SM; Vanscoy LL; McDougal KE; Bowers A; Naughton KM; Cutler DJ; Cutting GR
    Hum Mol Genet; 2008 Jul; 17(14):2228-37. PubMed ID: 18424453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21.
    Fernandez-Navarro P; González-Neira A; Pita G; Díaz-Uriarte R; Tais Moreno L; Ederra M; Pedraz-Pingarrón C; Sánchez-Contador C; Vázquez-Carrete JA; Moreo P; Vidal C; Salas-Trejo D; Stone J; Southey MC; Hopper JL; Pérez-Gómez B; Benitez J; Pollan M
    Int J Cancer; 2015 May; 136(10):2427-36. PubMed ID: 25353672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Common genetic variation and novel loci associated with volumetric mammographic density.
    Brand JS; Humphreys K; Li J; Karlsson R; Hall P; Czene K
    Breast Cancer Res; 2018 Apr; 20(1):30. PubMed ID: 29665850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy.
    Hada M; Oh H; Pfeiffer RM; Falk RT; Fan S; Mullooly M; Pollak M; Geller B; Vacek PM; Weaver D; Shepherd J; Wang J; Fan B; Mahmoudzadeh AP; Malkov S; Herschorn S; Brinton LA; Sherman ME; Gierach GL
    Breast Cancer Res; 2019 Jul; 21(1):81. PubMed ID: 31337427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.